PD-1 genetic fate mapping uncovers immune cell diversity mediating the efficacy of combined PD-1 blockade and chemotherapy. [PDF]
Yamaguchi A +10 more
europepmc +1 more source
Targeting estrogen receptor alpha in breast cancer for novel therapies resistance mechanisms and future directions. [PDF]
Wu BX +6 more
europepmc +1 more source
17β-Hydroxysteroid dehydrogenases 1 and 2: potential markers for breast cancer recurrence and tamoxifen resistance among premenopausal women diagnosed with breast cancer in Denmark. [PDF]
Collin LJ +15 more
europepmc +1 more source
Unexpected thrombocytopenia of a rare tamoxifen-induced complication in breast cancer therapy: A case report. [PDF]
Swamy AM, Sehrawat A, Sundriyal D.
europepmc +1 more source
Accidental tamoxifen ingestion in a two-year-old child without major immediate symptoms: Case report. [PDF]
de Groot ADE +6 more
europepmc +1 more source
Nano-curcumin enhances the sensitivity of tamoxifen-resistant breast cancer cells via the Cyclin D1-DILA1 axis and the PI3K/AKT/mTOR pathway downregulation. [PDF]
Givi T +6 more
europepmc +1 more source
Related searches:
Tamoxifen (TAM) is a selective estrogen receptor modulator that is used in the treatment of breast cancer. As there are estrogen receptors in the retina, retinal pigment epithelium, and choroid, these tissues may also be affected by TAM. We describe the reported effects of TAM on the retina and choroid.
Fatemeh Bazvand +6 more
openaire +2 more sources

